Amneal’s biosciences arm recently introduced its generic of Clolar (clofarabine, 1mg/ml). The Bridgewater, N.J.-based company will be shipping the product in a single-dose vial containing 20 mg of the active ingredient in 20 ml of clear sterile solution.
“We are pleased to expand our product portfolio with clofarabine,” Amneal Biosciences president Charles Lucarelli said. “It’s an important addition to our growing oncology line.”
The product had $53 million in sales for the 12 months ended September 2017, according to data from IQVIA.
December 5, 2017